BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 35779862)

  • 1. The Role of microRNA in the Development, Diagnosis, and Treatment of Cardiovascular Disease: Recent Developments.
    Wronska A
    J Pharmacol Exp Ther; 2023 Jan; 384(1):123-132. PubMed ID: 35779862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNAs as Candidate Drug Targets for Cardiovascular Diseases.
    Hang P; Guo J; Sun C; Du Z
    Curr Drug Targets; 2017; 18(4):463-472. PubMed ID: 26926467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miRNAS in cardiovascular diseases: potential biomarkers, therapeutic targets and challenges.
    Zhou SS; Jin JP; Wang JQ; Zhang ZG; Freedman JH; Zheng Y; Cai L
    Acta Pharmacol Sin; 2018 Jul; 39(7):1073-1084. PubMed ID: 29877320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA Signature and Cardiovascular Dysfunction.
    Arunachalam G; Upadhyay R; Ding H; Triggle CR
    J Cardiovasc Pharmacol; 2015 May; 65(5):419-29. PubMed ID: 25384197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HDL and microRNA therapeutics in cardiovascular disease.
    Michell DL; Vickers KC
    Pharmacol Ther; 2016 Dec; 168():43-52. PubMed ID: 27595929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNAs: a novel class of potential therapeutic targets for cardiovascular diseases.
    Pan ZW; Lu YJ; Yang BF
    Acta Pharmacol Sin; 2010 Jan; 31(1):1-9. PubMed ID: 19966833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miRNAs as potential therapeutic targets and diagnostic biomarkers for cardiovascular disease with a particular focus on WO2010091204.
    Yang Y; Yu T; Jiang S; Zhang Y; Li M; Tang N; Ponnusamy M; Wang JX; Li PF
    Expert Opin Ther Pat; 2017 Sep; 27(9):1021-1029. PubMed ID: 28627982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA and Cardiovascular Diseases.
    Çakmak HA; Demir M
    Balkan Med J; 2020 Feb; 37(2):60-71. PubMed ID: 32018347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. microRNAs in cardiovascular disease - clinical application.
    Schulte C; Karakas M; Zeller T
    Clin Chem Lab Med; 2017 May; 55(5):687-704. PubMed ID: 27914211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating microRNAs as Potential Biomarkers in Pancreatic Cancer-Advances and Challenges.
    Seyhan AA
    Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37686149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of microRNAs in diagnosis and treatment of cardiovascular disease.
    Wronska A; Kurkowska-Jastrzebska I; Santulli G
    Acta Physiol (Oxf); 2015 Jan; 213(1):60-83. PubMed ID: 25362848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Small Molecules with Big Impacts on Cardiovascular Diseases.
    Mirzadeh Azad F; Arabian M; Maleki M; Malakootian M
    Biochem Genet; 2020 Jun; 58(3):359-383. PubMed ID: 31997044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-143/-145 in Cardiovascular Diseases.
    Zhao W; Zhao SP; Zhao YH
    Biomed Res Int; 2015; 2015():531740. PubMed ID: 26221598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. microRNAs in Cardiovascular Disease: Small Molecules but Big Roles.
    Yan B; Wang H; Tan Y; Fu W
    Curr Top Med Chem; 2019; 19(21):1918-1947. PubMed ID: 31393249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNAs and ultraconserved genes as diagnostic markers and therapeutic targets in cancer and cardiovascular diseases.
    Edwards JK; Pasqualini R; Arap W; Calin GA
    J Cardiovasc Transl Res; 2010 Jun; 3(3):271-9. PubMed ID: 20560048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNAs in Cardiovascular Disease.
    Barwari T; Joshi A; Mayr M
    J Am Coll Cardiol; 2016 Dec; 68(23):2577-2584. PubMed ID: 27931616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miRNA and cancer; computational and experimental approaches.
    Tutar Y
    Curr Pharm Biotechnol; 2014; 15(5):429. PubMed ID: 25189575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating miRNAs as biomarkers in cardiovascular diseases.
    Kaneto CM; Nascimento JS; Prado MSJG; Mendonça LSO
    Eur Rev Med Pharmacol Sci; 2019 Mar; 23(5):2234-2243. PubMed ID: 30915771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNAs As Master Regulators of Atherosclerosis: From Pathogenesis to Novel Therapeutic Options.
    Hosen MR; Goody PR; Zietzer A; Nickenig G; Jansen F
    Antioxid Redox Signal; 2020 Sep; 33(9):621-644. PubMed ID: 32408755
    [No Abstract]   [Full Text] [Related]  

  • 20. MicroRNAs and Cardiovascular Disease Risk.
    Searles CD
    Curr Cardiol Rep; 2024 Feb; 26(2):51-60. PubMed ID: 38206553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.